Monaco Asset Management SAM »

Fate Therapeutics shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2024-12-31 $541k 328k 1.65
2024-09-30 $482k 138k 3.50
2024-06-30 $941k 287k 3.28
2024-03-31 $2.3M 317k 7.34
2023-12-31 $8.2M 2.2M 3.74
2023-09-30 $3.9M 1.8M 2.12
2023-06-30 $4.8M 1.0M 4.76
2023-03-31 $5.5M 970k 5.70
2022-12-31 $2.5M 250k 10.09

More positions owned by Monaco Asset Management SAM

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Viatris (VTRS)
Ishares Msci Brazil Etf Call Option (EWZ)
Palantir Technologies Cl A Put Option (PLTR)
Costco Wholesale Corporation Put Option (COST)
Barrick Gold Corp (GOLD)
NVIDIA Corporation Put Option (NVDA)
Baidu Spon Adr Rep A (BIDU)
Walgreen Boots Alliance (WBA)
Alibaba Group Hldg Sponsored Ads (BABA)
Wal-Mart Stores Put Option (WMT)
Paramount Global Class B Com (PARA)
Apple Put Option (AAPL)
Chimerix (CMRX)
Patterson-UTI Energy (PTEN)

View all positions for Monaco Asset Management SAM

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Deep Track Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
Baker Bros. Advisors
EcoR1 Capital
Dimensional Fund Advisors
Morgan Stanley
Goldman Sachs Group
State Street Corporation
Geode Capital Management

View all funds holding Fate Therapeutics